青島港(601298.SH):青島市國資委完成劃轉公司控股股東49%股權
格隆匯12月2日丨青島港(601298.SH)公佈,青島市國資委擬將公司控股股東青島港集團49%股權無償劃轉至山東省港口集團,並取得了山東省人民政府國有資產監督管理委員會的批准。
2020年12月2日,公司收到青島港集團《關於青島港(集團)有限公司完成工商變更登記的通知》,確認青島港集團工商變更登記手續已辦理完成。變更完成後,青島市國資委持有青島港集團51%股權,山東省港口集團持有青島港集團49%股權。
至此,本次無償劃轉事項已經全部完成。公司的控股股東仍為青島港集團,公司的實際控制人仍為青島市國資委。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.